doi: 10.3389/fimmu.2024.1389173 Received 21 February 2024 Accepted 10 April 2024 Published 29 April 2024 Volume 15 - 2024 Edited by Shensi Shen, Sichuan University, China Reviewed by Daoming Zhu, Southern Medical University, China Joanna Rossowska, Polish Academy of Sciences, Poland Updates Copyright 2024 Wang, Ma, Xie, Miao, lv, Huang, Zhang, Yu, Tai, Zhu and Bao
Gholami, Z., Clark, C
Imae et al
Anticancer Drug Encapsulation Use Case: Chemotherapeutic delivery with reduced toxicity Challenge: Many anticancer agents (e.g., doxorubicin, paclitaxel) are highly potent but poorly soluble and systemically toxic
It has been identified as a promising therapeutic candidate for fibrotic disorders due to its ability to decrease senescence and reverse apoptosis resistance in myofibroblasts [14, 15]
They represent a new option that wasnt available even a few years ago